SHC2 anticorps (AA 161-270) (Cy3)
-
- Antigène Voir toutes SHC2 Anticorps
- SHC2 (SHC (Src Homology 2 Domain Containing) Transforming Protein 2 (SHC2))
-
Épitope
- AA 161-270
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SHC2 est conjugé à/à la Cy3
-
Application
- Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))
- Homologie
- Human,Mouse,Rat,Dog,Cow,Sheep
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human SHC2/Sck
- Isotype
- IgG
- Top Product
- Discover our top product SHC2 Anticorps primaire
-
-
- Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- SHC2 (SHC (Src Homology 2 Domain Containing) Transforming Protein 2 (SHC2))
- Autre désignation
- SHC2/Sck (SHC2 Produits)
- Synonymes
- anticorps SCK, anticorps SHCB, anticorps SLI, anticorps 6720466E06, anticorps ShcB, anticorps Sli, anticorps SHC adaptor protein 2, anticorps SHC (Src homology 2 domain containing) transforming protein 2, anticorps SHC2, anticorps Shc2
- Sujet
-
Synonyms: Protein Sck, SCK, SH2 domain protein C2, SHC transforming protein 2, SHCB, Src homology 2 domain containing transforming protein C2, SHC2_HUMAN.
Background: Src homology 2 (SH2) domains bind specifically to tyrosine-phosphorylated proteins that temporally participate in signal transduction events (1). Shc-like protein (Sck) is a neuronal adaptor protein that contains an N-terminal PTB (phosphotyrosine binding) domain, a collagen homology (CH) domain, and a conserved C-terminal SH2 domain (2,3). Human Sck transcripts are present at high levels in liver, pancreas, prostate and ovary (4,5). In vascular endothelial cells, Sck participates in VEGF-induced signal transduction (6). Treatment of human umbilical vein endothelial (HUVEC) cells with VEGF induces recruitment of Sck to tyrosine-1175 of the kinase insert domain-containing receptor (KDR) and enhances Sck tyrosine phosphorylation (7,8).
- Pathways
- Signalisation RTK, Neurotrophin Signaling Pathway, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals, VEGF Signaling
-